Feasibility study of adjuvant nab-paclitaxel in breast cancer
Not Applicable
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000007725
- Lead Sponsor
- Graduate school of medicine,Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1)Serious drug hypersensitivity 2)Other any cancer 3)Other severe complications 4)Symptomatic brain metastasis 5)Severe mental disorders 6)Active bleeding of digestive tract 7)Serious myeloablation,renal insufficciency,liver failure 8)Massive hydrothorax or ascites 9)Diarrhea 10)Active infection 11)Allergy of the Nab-paclitaxel,paclitaxel or albumin 12)Pregnant 13)Serious Docetaxel and Polysorbate-80 hypersensitivity 14)Not suitable for participating in the study for any other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Completion rate
- Secondary Outcome Measures
Name Time Method Safety,RDI,DFS